— Know what they know.
Not Investment Advice

IRON

Disc Medicine, Inc.
1W: +5.8% 1M: -5.5% 3M: -21.4% YTD: -20.9% 1Y: +16.5% 3Y: +189.4% 5Y: -64.5%
$62.55
+2.94 (+4.93%)
After Hours: $58.91 (-3.64, -5.83%)
NASDAQ · Healthcare · Biotechnology · $2.4B · Alpha Radar Sell · Power 41
Smart Money Score
Bullish 75
Insider+$15.7M
Congress
ETF Holdings
Key Statistics
Market Cap$2.4B
52W Range30.82-99.5
Volume466,806
Avg Volume700,435
Beta2.66
Dividend
Analyst Ratings
11 Buy 0 Hold 0 Sell
Consensus Buy
Company Info
CEOJohn D. Quisel
Employees94
SectorHealthcare
IndustryBiotechnology
IPO Date2020-08-12
321 Arsenal Street
Watertown, MA 02472
US
617 674 9274
About Disc Medicine, Inc.

Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. It builds a portfolio of therapeutic candidates that address a spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, primarily heme biosynthesis and iron homeostasis. The company is based in Watertown, Massachusetts.

Recent Insider Trades

NameTypeSharesPriceDate
Savage William Jacob S-Sale 4,392 $65.52 2026-03-02
Savage William Jacob S-Sale 2,986 $66.41 2026-03-02
Franchi Jean M. S-Sale 353 $69.06 2026-02-25
Franchi Jean M. S-Sale 3,397 $65.01 2026-02-18
Franchi Jean M. S-Sale 3,684 $65.89 2026-02-18

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms